WC
BMY icon

Waterloo Capital’s Bristol-Myers Squibb BMY Stock Holding History

Waterloo Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$568K Sell
9,856
-110
-1% -$6.32K 0.03% 331
2026
Q1 		$604K Buy
9,966
+3,400
+52% +$198K 0.04% 275
2025
Q4 		$354K Sell
6,566
-2,540
-28% -$122K 0.03% 349
2025
Q3 		$411K Sell
9,106
-10,596
-54% -$495K 0.03% 316
2025
Q2 		$912K Sell
19,702
-30,245
-61% -$1.48M 0.07% 189
2025
Q1 		$3.05M Buy
49,947
+19,376
+63% +$1.13M 0.28% 94
2024
Q4 		$1.73M Buy
30,571
+26,612
+672% +$1.49M 0.18% 124
2024
Q3 		$205K Buy
+3,959
New +$186K 0.02% 343

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Waterloo Capital's BMY Position: Q2 2026 in Review

Waterloo Capital reduced its Bristol-Myers Squibb (BMY) stake by 1.1% in Q2 2026, selling an estimated $6.32K and leaving 9,856 shares worth $568K. The position accounts for 0.03% of the portfolio, ranked #331.

Waterloo Capital first reported a position in BMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.05M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Waterloo Capital held 9,856 shares of Bristol-Myers Squibb worth $568K as of Q2 2026.
  • Waterloo Capital sold 110 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.32K.
  • Bristol-Myers Squibb made up 0.03% of Waterloo Capital's portfolio in Q2 2026, its #331 holding.
  • Waterloo Capital first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 8 quarters since.
  • Waterloo Capital's Bristol-Myers Squibb position peaked at $3.05M in Q1 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.